High expression of miR-330-3p was related to the tumor size (p < 0.0001), advanced TNM stage (p < 0.0001), lymph node metastasis (p = 0.001), pathological stage (p = 0.012), and HER-2 amplification (p = 0.001). Here, ERBB2 is linked to neoplasm.